{"help": "https://donnees.iriu.ca/fr/api/3/action/help_show?name=datastore_search", "success": true, "result": {"include_total": true, "limit": 100, "records_format": "objects", "resource_id": "39c91df7-6086-4f8d-aa92-44f2c47784c8", "total_estimation_threshold": null, "records": [{"_id":1,"Product brand name and formulation":"","Novavax Nuvaxovid":"Royal blue cap and orange label border\n(Omicron  XBB.1.5 subvariant)\n10 mcg/mL"},{"_id":2,"Product brand name and formulation":"DIN/SNOMED","Novavax Nuvaxovid":"02543656/51491000087100"},{"_id":3,"Product brand name and formulation":"Type of vaccine","Novavax Nuvaxovid":"Protein subunit"},{"_id":4,"Product brand name and formulation":"Antigen component","Novavax Nuvaxovid":"One dose (0.5 mL) contains 5 mcg of SARS-CoV-2 recombinant Omicron XBB.1.5 subvariant spike protein."},{"_id":5,"Product brand name and formulation":"Date of authorization in Canada","Novavax Nuvaxovid":"December 5, 2023 (for 12 years of age and older)."},{"_id":6,"Product brand name and formulation":"Authorized ages for useFootnote a","Novavax Nuvaxovid":"12 years of age and older."},{"_id":7,"Product brand name and formulation":"Authorized dose","Novavax Nuvaxovid":"0.5 mL(5 mcg of Omicron XBB.1.5 subvariant spike protein)."},{"_id":8,"Product brand name and formulation":"Authorized scheduleFootnote a","Novavax Nuvaxovid":"2 doses, 3 weeks apart for 12 years of age and older for those not previously vaccinated.1 dose for 12 years of age and older who were previously vaccinated with an interval of at least 6 months from the most recent previous COVID-19 vaccine dose."},{"_id":9,"Product brand name and formulation":"Nature of the antigen","Novavax Nuvaxovid":"Recombinant prefusion spike protein of the Omicron subvariant XBB.1.5"},{"_id":10,"Product brand name and formulation":"Potential allergens","Novavax Nuvaxovid":"Polysorbate 80"},{"_id":11,"Product brand name and formulation":"Adjuvant (if present)","Novavax Nuvaxovid":"Matrix-M; comes premixed with the product"},{"_id":12,"Product brand name and formulation":"StorageFootnote b","Novavax Nuvaxovid":"Unopened vials can be       refrigerated  (2°C to 8°C) for up to 12 months.Once punctured, vials can be       stored at room temperature (8°C to 25°C) for a total of up to 6 hours or       refrigerated (2°C to 8°C) for up to 12 hours.Do not freeze.Do not use beyond expiry date."},{"_id":13,"Product brand name and formulation":"Transport","Novavax Nuvaxovid":"Before puncture:After puncture:2°C to 8°C and the temperature monitored during transport.Open vials may be transported at 2°C to 8°C for up to 12 hours or at room temperature (up to 25°C) for up to 6 hours.A loaded syringe should not be transported aside from routine foot traffic in a clinical or medical setting."},{"_id":14,"Product brand name and formulation":"Handling instructions","Novavax Nuvaxovid":"Gently swirl the multidose vial before and in between each dose withdrawal. Do not shake.Prior to administration, visually inspect the contents of the vial for visible particulate matter or discolouration. Also, visually inspect the vial for cracks or any abnormalities, such as evidence of tampering. If any of these conditions exists, the vaccine should not be administered.Mark the date and time that the product should be discarded on the label (12 hours after first puncture).Do not dilute."},{"_id":15,"Product brand name and formulation":"Reconstitution","Novavax Nuvaxovid":"No."},{"_id":16,"Product brand name and formulation":"Route of administration","Novavax Nuvaxovid":"Intramuscular"},{"_id":17,"Product brand name and formulation":"Syringe and needle selectionFootnote cFootnote d","Novavax Nuvaxovid":"22- to 25-gauge needle for administration."},{"_id":18,"Product brand name and formulation":"Formats available","Novavax Nuvaxovid":"Multidose vial.5 mcg/0.5 mL; 2.5 mL in a vial; 5 doses of 0.5 mL.Preservative-free."},{"_id":19,"Product brand name and formulation":"Expiry date","Novavax Nuvaxovid":"Do not use this vaccine after the expiry date, which is stated on the label after EXP. The expiry date refers to the last day of that month."},{"_id":20,"Product brand name and formulation":"Footnote a\nAuthorized per the product monograph. The National Advisory Committee on Immunization (NACI) recommendations may differ. Refer to theNACI statements or theCOVID-19 vaccines chapter of the Canadian Immunization Guide.\nReturn to footnote areferrerFootnote b\nProtected from light during storage.\nReturn to footnote breferrerFootnote c\nRefer to theCanadian Immunization Guide for needle selection guidelines.\nReturn to footnote creferrerFootnote d\nSource:Vaccine administration practices: Canadian Immunization Guide.\nReturn to footnote dreferrer","Novavax Nuvaxovid":""}], "fields": [{"id": "_id", "type": "int"}, {"id": "Product brand name and formulation", "type": "text"}, {"id": "Novavax Nuvaxovid", "type": "text"}], "_links": {"start": "/api/action/datastore_search?resource_id=39c91df7-6086-4f8d-aa92-44f2c47784c8", "next": "/api/action/datastore_search?resource_id=39c91df7-6086-4f8d-aa92-44f2c47784c8&offset=100"}, "total": 20, "total_was_estimated": false}}